Organization
Cephalon
5 clinical trials
Clinical trial
Prospective, Open-Label, Randomized Study of Combination Therapy of MYOCET® Plus Cyclophosphamide and Trastuzumab Versus Free Doxorubicin Plus Cyclophosphamide Alone, Each Followed by Docetaxel and Trastuzumab, in Neoadjuvant Setting in Treatment-Naive Patients With HER2-Positive Breast CancerStatus: Completed, Estimated PCD: 2015-09-17
Clinical trial
The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy RegistryStatus: Terminated, Estimated PCD: 2023-11-30
Clinical trial
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of CEP-33457 in Patients With Systemic Lupus ErythematosusStatus: Completed, Estimated PCD: 2012-01-31
Clinical trial
An Open-Label Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus ErythematosusStatus: Terminated, Estimated PCD: 2012-06-14
Clinical trial
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety of GABITRIL at Dosages up to 16mg/Day in Adults With Generalized Anxiety DisorderStatus: , Estimated PCD: 2005-02-01